Deucravacitinib is an Orally Active TYK2 Allosteric Inhibitor for Autoimmune Diseases Research
Tyrosine kinase 2 (TYK2) is a member of the JAK kinase family. Besides, it regulates signal transduction downstream of the IL-23/IL-12 pathway and the type I interferon family receptor, pairing…